Entrada Therapeutics Correlations

TRDA Stock

USD 12.12 0.10 0.83%

The current 90-days correlation between Entrada Therapeutics and Monte Rosa Therapeutics is 0.3 (i.e., Weak diversification). The correlation of Entrada Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Entrada Therapeutics Correlation With Market

Significant diversification

The correlation between Entrada Therapeutics and DJI is 0.09 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Entrada Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Entrada Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

For information on how to trade Entrada Stock refer to our How to Trade Entrada Stock guide.

Moving together with Entrada Stock

0.64	ILMN	Illumina	Pair Corr
0.91	INZY	Inozyme Pharma	Pair Corr
0.68	KURA	Kura Oncology	Pair Corr
0.89	ABOS	Acumen Pharmaceuticals	Pair Corr
0.92	ADTX	Aditxt Inc	Pair Corr
0.78	STRO	Sutro Biopharma	Pair Corr
0.87	TCRX	Tscan Therapeutics	Pair Corr
0.94	TERN	Terns Pharmaceuticals	Pair Corr
0.97	CRNX	Crinetics Pharmaceuticals	Pair Corr
0.88	CTMX	CytomX Therapeutics	Pair Corr
0.76	DAWN	Day One Biopharmaceu	Pair Corr
0.61	TLKMF	Telkom Indonesia Tbk	Pair Corr

Moving against Entrada Stock

0.73	OPT	Opthea	Pair Corr
0.71	PHGE	Biomx Inc	Pair Corr
0.68	GANX	Gain Therapeutics	Pair Corr
0.65	LTRN	Lantern Pharma	Pair Corr
0.59	CUE	Cue Biopharma	Pair Corr
0.54	PFE	Pfizer Inc Aggressive Push	Pair Corr
0.46	A	Agilent Technologies	Pair Corr
0.38	FENC	Fennec Pharmaceuticals	Pair Corr
0.73	DBVT	DBV Technologies Earnings Call This Week	Pair Corr
0.56	CGTX	Cognition Therapeutics	Pair Corr
0.48	CPRX	Catalyst Pharmaceuticals	Pair Corr
0.92	OBI	Ondine Biomedical	Pair Corr
0.8	SSNLF	Samsung Electronics	Pair Corr
0.74	GPI	Group 1 Automotive	Pair Corr
0.7	EC	Ecopetrol SA ADR	Pair Corr

Related Correlations Analysis

	MOLN	PMVP	GLUE	VIGL	THRD	CGEM	EWTX	RLYB	CRNX	CNTA
MOLN		0.47	0.49	-0.22	0.58	0.58	0.55	0.7	0.52	-0.02	MOLN
PMVP	0.47		0.88	-0.06	0.87	0.81	0.71	0.81	0.91	0.43	PMVP
GLUE	0.49	0.88		0.11	0.75	0.74	0.77	0.77	0.81	0.53	GLUE
VIGL	-0.22	-0.06	0.11		-0.34	-0.27	0.06	-0.29	-0.28	0.18	VIGL
THRD	0.58	0.87	0.75	-0.34		0.93	0.72	0.89	0.97	0.32	THRD
CGEM	0.58	0.81	0.74	-0.27	0.93		0.73	0.86	0.91	0.36	CGEM
EWTX	0.55	0.71	0.77	0.06	0.72	0.73		0.68	0.76	0.42	EWTX
RLYB	0.7	0.81	0.77	-0.29	0.89	0.86	0.68		0.87	0.28	RLYB
CRNX	0.52	0.91	0.81	-0.28	0.97	0.91	0.76	0.87		0.41	CRNX
CNTA	-0.02	0.43	0.53	0.18	0.32	0.36	0.42	0.28	0.41		CNTA
	MOLN	PMVP	GLUE	VIGL	THRD	CGEM	EWTX	RLYB	CRNX	CNTA

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

CRNX	+ 0.97	THRD
CGEM	+ 0.93	THRD
CRNX	+ 0.91	PMVP
CRNX	+ 0.91	CGEM
RLYB	+ 0.89	THRD
GLUE	+ 0.88	PMVP

High negative correlations

THRD	- 0.34	VIGL
RLYB	- 0.29	VIGL
CRNX	- 0.28	VIGL
CGEM	- 0.27	VIGL
VIGL	- 0.22	MOLN
VIGL	- 0.06	PMVP

Risk-Adjusted Indicators

There is a big difference between Entrada Stock performing well and Entrada Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Entrada Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
MOLN	2.40	(0.12)	0.00	(0.09)	0.00	0.00	7.09	(4.88)	17.19
PMVP	1.73	(0.12)	0.00	0.65	0.00	0.00	4.38	(3.31)	9.70
GLUE	3.77	(0.29)	0.00	10.35	0.00	0.00	8.40	(8.27)	23.57
VIGL	4.13	(0.01)	0.00	(0.01)	0.00	0.00	7.87	(7.49)	33.24
THRD	4.19	(1.68)	0.00	17.38	0.00	0.00	7.29	(10.39)	40.45
CGEM	2.46	(0.62)	0.00	(1.52)	0.00	0.00	4.98	(6.27)	15.27
EWTX	2.69	(0.25)	0.00	0.28	0.00	0.00	4.81	(7.21)	26.44
RLYB	3.12	(0.33)	0.00	(0.45)	0.00	0.00	6.36	(6.19)	16.58
CRNX	2.61	(0.72)	0.00	1.19	0.00	0.00	3.12	(7.53)	21.52
CNTA	3.04	0.03	0.01	(1.40)	3.64	(3.08)	6.67	(6.19)	15.71

Entrada Therapeutics Corporate Management

Kory CPA	CFO Treasurer	Profile
Kerry MS	Senior People	Profile
Jared JD	General Counsel	Profile
Nathan Dowden	Chief Officer	Profile
Karla MacDonald	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC